Skip to content
Home » News » New York State » AG James leads coalition to protect medication abortion access

AG James leads coalition to protect medication abortion access

  • / Updated:
  • Staff Report 

New York Attorney General Letitia James has filed two amicus briefs in the U.S. Court of Appeals for the Fifth Circuit, leading two separate multistate coalitions in an effort to protect Americans’ access to the medication abortion drug mifepristone and preserve privacy protections over adolescents’ reproductive health care decisions. The briefs argue against separate decisions made by the same district court judge in the U.S. District Court for the Northern District of Texas that could negatively impact Americans’ access to medication abortion and privacy rights.


In Alliance for Hippocratic Medicine v. FDA, the coalition argues that the FDA’s determination that mifepristone is safe and effective is supported by a strong medical consensus. They urge the U.S. Court of Appeals for the Fifth Circuit to reverse the lower court ruling, stating that if it stands, millions of Americans, particularly underserved groups, will be affected.

In Deanda v. Becerra, the coalition argues that eliminating Title X’s confidentiality protections for adolescents in Texas would have severe consequences for teenage patients. They urge the U.S. Court of Appeals for the Fifth Circuit to reverse the lower court ruling, which threatens minors’ ability to secure Title X services without parental consent and goes against decades of established practices.

These amicus briefs are part of Attorney General James’ ongoing fight to protect Americans’ rights to privacy, health care options, and medication abortion access. She has led multi-state coalitions in submitting amicus briefs to combat efforts to rollback abortion rights and support access to safe, legal abortions.